Today: 3 July 2026
Bank of America stock rises 3% as Wall Street rebounds — what BAC traders are watching next
6 February 2026
2 mins read

Bank of America stock rises 3% as Wall Street rebounds — what BAC traders are watching next

NEW YORK, February 6, 2026, 14:58 EST — Regular session

Shares of Bank of America Corp rose roughly 3% Friday afternoon, picking up momentum with other U.S. bank stocks as investors got back into risk after a tough week. At 2:42 p.m. EST, the stock was higher by $1.65, trading at $56.59.

Stocks bounced, breaking a three-day losing streak for Wall Street and sending the Dow above 50,000 for the first time. Gains in the S&P 500 and Nasdaq followed, with chipmakers climbing after renewed talk on big-tech spending stirred up the sector.

What’s moving the needle for lenders right now? It’s rates, front and center—plus whatever expectations the market is baking in about the Fed’s appetite to keep pressure on with inflation still running above target. Early February saw a modest uptick in U.S. consumer sentiment, though worries about the job market stuck around. “We may have seen the trough in consumer sentiment,” Nationwide financial markets economist Oren Klachkin said. Reuters

Timing’s been tricky. With the January U.S. payrolls data delayed due to the government shutdown, traders have had to rely on less substantial cues while recalibrating expectations for the Fed’s trajectory. According to Reuters, futures markets suddenly assigned a much greater probability to a March quarter-point cut compared with just a day before.

JPMorgan Chase tacked on close to 4%. Wells Fargo advanced approximately 3%. Citigroup? Up about 5%. Other money-center banks followed suit.

Bank of America, for its part, made an announcement late Thursday: the bank plans to redeem every outstanding share of its Series DD preferred stock, as well as the associated depositary shares, on March 10. Holders will get $1,000 per depositary share. The Series DD stock ranks above common shares and pays out dividends.

Bank of America is making a bigger play in credit cards, investing “hundreds of millions of dollars” into the business, according to Mary Hines Droesch, the bank’s head of consumer and small-business products and analytics. Updates to its rewards program are on deck for later this month, she said in an interview with Banking Dive. Banking Dive

The group isn’t letting politics fade into the background. Major U.S. banks have ramped up lobbying budgets in 2025, with Washington scrutinizing capital requirements, crypto regulation, and consumer proposals like the possible cap on credit card rates. Ed Mills, policy analyst at Raymond James, said the aim is to be “fully at the table.” Reuters

The real worry for BAC and rivals? Fresh labor or inflation numbers could upend rate bets again. San Francisco Fed President Mary Daly called the outlook “precarious.” Now, all eyes are on the delayed jobs report—key for both policymakers and investors. Reuters

The Bureau of Labor Statistics has pushed the January Employment Situation report to Wednesday, Feb. 11, 8:30 a.m. ET. January CPI lands two days later—Friday, Feb. 13, same time. Both data drops have the potential to jolt Treasury yields and, by extension, Bank of America shares.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Johnson & Johnson (JNJ) Closes Above Analyst Target With Q2 Earnings Coming Up
    July 2, 2026, 6:04 PM EDT. Johnson & Johnson (NYSE: JNJ) finished at $263.04, up 3.57%. That's a 52-week high and above the average analyst target of $262.10. The stock sits just below the $265 median ahead of Q2 earnings on July 15. EPS forecasts for 2026 stay at about $11.58. J&J's market cap climbed by $21.8 billion, with volume close to the 65-day average. S&P 500 was flat and the Nasdaq dropped, but J&J beat the Dow's 1.14% gain. The company's 2026 start got a boost from April numbers-Innovative Medicine sales up 11.2%, MedTech up 7.7%. Traders are watching as earnings draw closer.
Confluent stock edges higher as IBM deal vote nears after fresh merger filing
Previous Story

Confluent stock edges higher as IBM deal vote nears after fresh merger filing

Amazon stock slides after $200 billion AI spending plan puts returns in the spotlight
Next Story

Amazon stock slides after $200 billion AI spending plan puts returns in the spotlight

Go toTop